Hispanics leery of health care providers, often avoid cancer screenings, study shows
When researchers at Moffitt Cancer Center and colleagues conducted a random telephone survey among blacks, whites and Hispanics in New York, Baltimore and San Juan, Puerto Rico, they found that Hispanics are nearly twice as likely to report that fear of being used as a "guinea pig" and lack of trust in medical professionals contribute in being unwilling to participate in cancer screenings. The researchers concluded that health care providers need to do a better job of instilling trust and dispelling certain fears, particularly among Hispanics, to improve cancer screening rates for lower-income minorities.
The study appeared in a supplement in the November issue of the Journal of Health Care for the Poor and Underserved.
"The provider-patient relationship is an important factor in patients adhering to cancer screening recommendations," said study senior author B. Lee Green, Ph.D., senior member of the Health Outcomes and Behavior Program at Moffitt. "This study found differences between sociodemographic groups in levels of fear and mistrust with regard to the provider-patient relationships and communications that may contribute to unwillingness to participate in cancer screenings."
According to the authors, the reasons for disparities in cancer screening behavior have been less apparent for minorities than for others, and few studies have aimed at understanding why.
The researchers found that when compared to whites, Hispanics were nearly twice as likely to report a fear of being a guinea pig, and a lack of trust in health care professionals would contribute to unwillingness to participate in cancer screenings. Noncollege-educated individuals with less than a high school education or diploma were found to be twice as likely as college graduates to fear embarrassment during screening.
Screening offers opportunities for early detection, diagnosis and treatment. Given the disparities in cancer screening utilization and the adverse health implications of such disparities, it is critical to understand the factors contributing to the problem, said the authors.
"The purpose of this analysis was to assess sociodemographic factors associated with fears and mistrust as related to the patient-provider relationship that may contribute to unwillingness to participate in cancer screenings," they wrote. "Our results indicate that racial, ethnic and educational discrepancies exist regarding fears and mistrust. Results also indicate areas where health professionals can improve interactions with patients, particularly among Hispanics and those with lower educational attainment."
The researchers added that communication can be especially difficult where there are language barriers, yet improving patient-provider communication "holds tremendous promise because it offers one of the more readily changeable contributors to cancer screening adherence."
The survey included responses from 355 blacks in New York and Baltimore, 311 Hispanics in San Juan and New York, and 482 whites in New York and Baltimore. They cities were chosen, said the authors, to ensure a wide geographic and racial/ethnic representation. The participants were 18 to 94 with incomes between less than $20,000 to more than $75,000 per year. Almost 40 percent has some or completed their high school education. College graduates or those with "some college" accounted for 46 percent of respondents.
The authors noted that their survey did not take into account respondents' health insurance status or the race or ethnicity of the respondent's health care provider.
Journal reference:
Journal of Health Care for the Poor and Underserved
Provided by
H. Lee Moffitt Cancer Center & Research Institute
-
Study evaluates factors associated with racial disparities in colon cancer screening
Jun 23, 2008 |
not rated yet |
0
-
Researchers find that sociodemographic characteristics are related to a patient's willingness to participate in cancer s
Mar 01, 2010 |
not rated yet |
0
-
Three fears may discourage colorectal cancer screening
Apr 30, 2012 |
not rated yet |
0
-
Gaps in colorectal cancer screening persist between whites and non-whites
Feb 18, 2009 |
not rated yet |
0
-
Racial disparities in colon cancer screening persist despite insurance, access
Dec 12, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be villous adenoma in colon, if there are no villi there
16 hours ago
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
American cancer society celebrates 100 years of progress
(HealthDay)—The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business.
Cancer
6 hours ago |
not rated yet |
0
CT detects twice as many lung cancers as X-ray at initial screening exam
National Lung Screening Trial (NLST) investigators also conclude that the 20 percent reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening previously reported in the ...
Cancer
6 hours ago |
not rated yet |
0
Research offers promising new approach to treatment of lung cancer
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...
Cancer
10 hours ago |
not rated yet |
0
|
Study details genes that control whether tumors adapt or die when faced with p53 activating drugs
When turned on, the gene p53 turns off cancer. However, when existing drugs boost p53, only a few tumors die – the rest resist the challenge. A study published in the journal Cell Reports shows how: tumors that live even i ...
Cancer
10 hours ago |
not rated yet |
0
|
Small increase in cancer risk following CT scans in childhood and adolescence
Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.
Cancer
14 hours ago |
not rated yet |
0
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Researchers complete largest genetic sequencing study of human disease
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Having both migraines, depression may mean smaller brain
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...